EP 0541597 A1 19930519 - HEXA-N-(O-HYDROXYBENZYL) NEOMYCIN B FOR INHIBITING HUMAN RETROVIRUSES AND FOR THE TREATMENT OF AIDS.
Title (en)
HEXA-N-(O-HYDROXYBENZYL) NEOMYCIN B FOR INHIBITING HUMAN RETROVIRUSES AND FOR THE TREATMENT OF AIDS.
Title (de)
HEXA-N-(0-HYDROXYBENZYL) NEOMYCIN B ZUR HEMMUNG VON MENSCHLICHEN RETROVIREN UND ZUR BEHANDLUNG VON AIDS.
Title (fr)
HEXA-N-(O-HYDROXYBENZYL) NEOMYCINE B DESTINEE A L'INHIBITION DES RETROVIRUS HUMAINS ET AU TRAITEMENT DU SIDA.
Publication
Application
Priority
US 55985190 A 19900730
Abstract (en)
[origin: WO9202530A1] N-poly-(o-hydroxybenzyl) Neomycin B or salts and/or hydrates thereof, can be used to treat humans infected with one or more than one strain of a human immunodeficiency virus.
Abstract (fr)
La N-poly-(o-hydroxybenzyl) Néomycine B, ou ses sels et/ou hydrates, peut servir au traitement des personnes infectées par une ou plusieurs souches d'un virus de l'immunodéficience humaine.
IPC 1-7
IPC 8 full level
A61K 31/70 (2006.01); A61K 31/7028 (2006.01); A61K 31/7034 (2006.01); A61K 31/7036 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); C07H 15/232 (2006.01)
CPC (source: EP)
A61K 31/70 (2013.01); A61P 31/12 (2017.12); A61P 31/18 (2017.12); C07H 15/232 (2013.01)
Citation (search report)
See references of WO 9202530A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU NL SE
DOCDB simple family (publication)
WO 9202530 A1 19920220; AU 640511 B2 19930826; AU 8230091 A 19920302; CA 2085367 A1 19920131; EP 0541597 A1 19930519; JP H05509306 A 19931222
DOCDB simple family (application)
US 9104849 W 19910716; AU 8230091 A 19910716; CA 2085367 A 19910716; EP 91913197 A 19910716; JP 51246291 A 19910716